Periscope Capital’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Periscope Capital’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$78.7K	Hold	90,000	–	–	0.01%	293
2026 Q2	$84.7K	Hold	90,000	–	–	0.01%	299
2026 Q1	$64.1K	Hold	90,000	–	–	0.01%	278
2025 Q4	$74.2K	Hold	90,000	–	–	0.01%	235
2025 Q3	$67.5K	Hold	90,000	–	–	0.01%	194
2025 Q2	$78.8K	Hold	90,000	–	–	0.02%	138
2025 Q1	$67.5K	Buy	+90,000	New	+$68.4K	0.03%	112

Other funds holding OACCW

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $14.8B AUM 38.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Periscope Capital's OACCW Position: Q3 2026 in Review

Periscope Capital held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q3 2026 at 90,000 shares worth $78.7K. The position accounts for 0.01% of the portfolio, ranked #293.

Periscope Capital first reported a position in OACCW in Q1 2025 and has held it in 7 quarters since. The position peaked at $84.7K in Q2 2026. 4 funds tracked by Wall St. Rank hold OACCW as of Q3 2026.

Periscope Capital held 90,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $78.7K as of Q3 2026.
Periscope Capital left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q3 2026.
Oaktree Acquisition Corp III Life Sciences Warrant made up 0.01% of Periscope Capital's portfolio in Q3 2026, its #293 holding.
Periscope Capital first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 7 quarters since.
Periscope Capital's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $84.7K in Q2 2026.
4 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q3 2026.

Based on Periscope Capital's 13F filing for Q3 2026, filed 6 Nov 2026.